2024 Q1 Form 10-K Financial Statement

#000107997324000315 Filed on February 29, 2024

View on sec.gov

Income Statement

Concept 2024 Q1 2023 Q4 2023
Revenue $30.42K $40.50K $40.50K
YoY Change
Cost Of Revenue $5.175K $2.510K $2.513K
YoY Change
Gross Profit $25.24K $37.99K $37.99K
YoY Change
Gross Profit Margin 82.99% 93.8% 93.8%
Selling, General & Admin $1.255M $1.480M $5.360M
YoY Change -7.7% 12.37% 23.66%
% of Gross Profit 4973.66% 3895.89% 14108.22%
Research & Development $4.621M $3.897M $15.90M
YoY Change 21.61% 2.25% 24.2%
% of Gross Profit 18305.45% 10257.78% 41863.93%
Depreciation & Amortization $365.6K $321.6K $1.036M
YoY Change 42.84% 12.1% 7.1%
% of Gross Profit 1448.23% 846.64% 2726.1%
Operating Expenses $4.621M $5.377M $15.90M
YoY Change 21.61% 4.85% -7.21%
Operating Profit -$5.851M -$5.339M -$21.23M
YoY Change 13.39% 23.84%
Interest Expense $176.4K $187.7K $673.6K
YoY Change -51.24% 3357.46% 221.2%
% of Operating Profit
Other Income/Expense, Net -$2.234K -$3.930K -$12.24K
YoY Change -128.89% -107.24% -144.97%
Pretax Income -$5.680M -$4.940M -$21.04M
YoY Change 3.72% -2.55% 22.1%
Income Tax $0.00
% Of Pretax Income
Net Earnings -$5.680M -$4.940M -$21.04M
YoY Change 3.72% -2.55% 22.1%
Net Earnings / Revenue -18673.48% -12196.74% -51943.19%
Basic Earnings Per Share -$0.05 -$0.18
Diluted Earnings Per Share -$0.05 -$0.04 -$0.18
COMMON SHARES
Basic Shares Outstanding 119.2M shares 116.9M shares 115.5M shares
Diluted Shares Outstanding 119.0M shares 115.5M shares

Balance Sheet

Concept 2024 Q1 2023 Q4 2023
SHORT-TERM ASSETS
Cash & Short-Term Investments $31.51M $31.43M $31.43M
YoY Change 20.41% 30.41% 30.41%
Cash & Equivalents $31.51M $31.43M $31.43M
Short-Term Investments
Other Short-Term Assets $696.7K $1.238M $1.238M
YoY Change -0.93% 102.44% 102.44%
Inventory
Prepaid Expenses
Receivables $56.76K $30.38K $30.38K
Other Receivables $0.00 $0.00
Total Short-Term Assets $32.26M $32.70M $32.70M
YoY Change 20.06% 28.97% 28.97%
LONG-TERM ASSETS
Property, Plant & Equipment $5.397M $4.991M $7.829M
YoY Change 115.09% 98.1% 172.07%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $9.475M $9.084M $9.084M
YoY Change 140.57% 132.44% 132.44%
TOTAL ASSETS
Total Short-Term Assets $32.26M $32.70M $32.70M
Total Long-Term Assets $9.475M $9.084M $9.084M
Total Assets $41.74M $41.78M $41.78M
YoY Change 35.47% 42.78% 42.78%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $1.000M $1.448M $1.761M
YoY Change 174.45% 82.85% 97.47%
Accrued Expenses $650.0K $743.6K $743.6K
YoY Change 99.78% 30.35% 30.35%
Deferred Revenue $39.88K
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $1.812M $2.583M $2.583M
YoY Change 118.15% 71.73% 71.73%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities $2.727M $2.767M $2.767M
YoY Change 1761.49% 1240.39% 1240.39%
Total Long-Term Liabilities $2.727M $2.767M $2.767M
YoY Change 1761.45% 1240.42% 1240.39%
TOTAL LIABILITIES
Total Short-Term Liabilities $1.812M $2.583M $2.583M
Total Long-Term Liabilities $2.727M $2.767M $2.767M
Total Liabilities $4.539M $5.350M $5.350M
YoY Change 364.55% 212.77% 212.77%
SHAREHOLDERS EQUITY
Retained Earnings -$133.6M -$127.9M
YoY Change 18.91% 19.69%
Common Stock $119.8K $118.1K
YoY Change -99.92% -99.91%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $37.20M $36.43M $36.43M
YoY Change
Total Liabilities & Shareholders Equity $41.74M $41.78M $41.78M
YoY Change 35.47% 42.78% 42.78%

Cashflow Statement

Concept 2024 Q1 2023 Q4 2023
OPERATING ACTIVITIES
Net Income -$5.680M -$4.940M -$21.04M
YoY Change 3.72% -2.55% 22.1%
Depreciation, Depletion And Amortization $365.6K $321.6K $1.036M
YoY Change 42.84% 12.1% 7.1%
Cash From Operating Activities -$4.772M -$2.322M -$12.24M
YoY Change 27.3% -16.03% 16.91%
INVESTING ACTIVITIES
Capital Expenditures $775.4K $1.571M $3.292M
YoY Change 215.13% 350.98% 151.86%
Acquisitions
YoY Change
Other Investing Activities $0.00 $2.710K $642.7K
YoY Change -100.0% -105.02% -200.09%
Cash From Investing Activities -$828.5K -$1.571M -$2.957M
YoY Change -386.08% 290.51% 33.83%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities $5.678M 4.449M $22.52M
YoY Change 2.76% 97.86% 68.77%
NET CHANGE
Cash From Operating Activities -$4.772M -2.322M -$12.24M
Cash From Investing Activities -$828.5K -1.571M -$2.957M
Cash From Financing Activities $5.678M 4.449M $22.52M
Net Change In Cash $76.97K 555.4K $7.330M
YoY Change -96.27% -160.41% 994.77%
FREE CASH FLOW
Cash From Operating Activities -$4.772M -$2.322M -$12.24M
Capital Expenditures $775.4K $1.571M $3.292M
Free Cash Flow -$5.548M -$3.893M -$15.53M
YoY Change 38.87% 25.03% 31.9%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023 dei Amendment Flag
AmendmentFlag
false
CY2023 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
CY2023 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2023 dei Entity Central Index Key
EntityCentralIndexKey
0001325964
CY2022Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
usd
CY2023Q4 us-gaap Accounts And Notes Receivable Net
AccountsAndNotesReceivableNet
usd
CY2022Q4 us-gaap Deferred Revenue
DeferredRevenue
usd
CY2023Q4 lwlg Deferred Lease Liability Non Current
DeferredLeaseLiabilityNonCurrent
usd
CY2023Q4 us-gaap Preferred Stock Value
PreferredStockValue
usd
CY2022Q4 us-gaap Preferred Stock Value
PreferredStockValue
usd
CY2022 us-gaap Revenues
Revenues
usd
CY2021 us-gaap Revenues
Revenues
usd
CY2022 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
usd
CY2021 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
usd
CY2023 lwlg Paycheck Protection Program Loan Forgiveness
PaycheckProtectionProgramLoanForgiveness
usd
CY2022 lwlg Paycheck Protection Program Loan Forgiveness
PaycheckProtectionProgramLoanForgiveness
usd
CY2022 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
usd
CY2021 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
usd
CY2021 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
usd
CY2023 us-gaap Stock Issued During Period Value Restricted Stock Award Gross
StockIssuedDuringPeriodValueRestrictedStockAwardGross
usd
CY2022 us-gaap Stock Issued During Period Value Restricted Stock Award Gross
StockIssuedDuringPeriodValueRestrictedStockAwardGross
usd
CY2022 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
usd
CY2023 us-gaap Adjustment Of Warrants Granted For Services
AdjustmentOfWarrantsGrantedForServices
usd
CY2022 us-gaap Adjustment Of Warrants Granted For Services
AdjustmentOfWarrantsGrantedForServices
usd
CY2021 lwlg Amortization Of Deferred Compensation
AmortizationOfDeferredCompensation
usd
CY2023 lwlg Cashless Option Exercise
CashlessOptionExercise
usd
CY2022 lwlg Gain On Disposal Of Property And Equipment
GainOnDisposalOfPropertyAndEquipment
usd
CY2021 lwlg Gain On Disposal Of Property And Equipment
GainOnDisposalOfPropertyAndEquipment
usd
CY2023 lwlg Paycheck Protection Program Loan Forgiveness
PaycheckProtectionProgramLoanForgiveness
usd
CY2022 lwlg Paycheck Protection Program Loan Forgiveness
PaycheckProtectionProgramLoanForgiveness
usd
CY2022 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
usd
CY2021 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
usd
CY2022 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
usd
CY2021 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
usd
CY2021 lwlg Repayment Issuance Of Loan
RepaymentIssuanceOfLoan
usd
CY2022 us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
usd
CY2021 us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
usd
CY2023 lwlg Cashless Option Exercise Tax Payments
CashlessOptionExerciseTaxPayments
usd
CY2022 lwlg At Market Sale By Investment Banking Company
AtMarketSaleByInvestmentBankingCompany
usd
CY2021 lwlg At Market Sale By Investment Banking Company
AtMarketSaleByInvestmentBankingCompany
usd
CY2023 lwlg Repayment Of Equipment Purchased
RepaymentOfEquipmentPurchased
usd
CY2022 lwlg Repayment Of Equipment Purchased
RepaymentOfEquipmentPurchased
usd
CY2022 lwlg Operating Leases Liability
OperatingLeasesLiability
usd
CY2021 lwlg Operating Leases Liability
OperatingLeasesLiability
usd
CY2023Q4 us-gaap Contract With Customer Asset Net Current
ContractWithCustomerAssetNetCurrent
usd
CY2023Q4 us-gaap Contract With Customer Asset Net Noncurrent
ContractWithCustomerAssetNetNoncurrent
usd
CY2023Q4 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
usd
CY2022Q4 lwlg Prepaid Materials Fabrication
PrepaidMaterialsFabrication
usd
CY2022Q4 lwlg Leases Incentive Receivable
LeasesIncentiveReceivable
usd
CY2023Q4 lwlg Legal
Legal
usd
CY2023Q4 us-gaap Other Receivables Net Current
OtherReceivablesNetCurrent
usd
CY2023 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
usd
CY2022 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
usd
CY2021 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
usd
CY2023 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
CY2022 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
CY2021 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
CY2023 us-gaap Effective Income Tax Rate Reconciliation Deductions
EffectiveIncomeTaxRateReconciliationDeductions
pure
CY2022 us-gaap Effective Income Tax Rate Reconciliation Deductions
EffectiveIncomeTaxRateReconciliationDeductions
pure
CY2021 us-gaap Effective Income Tax Rate Reconciliation Deductions
EffectiveIncomeTaxRateReconciliationDeductions
pure
CY2023 us-gaap Income Tax Reconciliation Tax Exempt Income
IncomeTaxReconciliationTaxExemptIncome
usd
CY2023 us-gaap Effective Income Tax Rate Reconciliation Tax Exempt Income
EffectiveIncomeTaxRateReconciliationTaxExemptIncome
pure
CY2022 us-gaap Income Tax Reconciliation Tax Exempt Income
IncomeTaxReconciliationTaxExemptIncome
usd
CY2022 us-gaap Effective Income Tax Rate Reconciliation Tax Exempt Income
EffectiveIncomeTaxRateReconciliationTaxExemptIncome
pure
CY2021 us-gaap Effective Income Tax Rate Reconciliation Share Based Compensation Excess Tax Benefit Amount
EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount
usd
CY2021 us-gaap Effective Income Tax Rate Reconciliation Share Based Compensation Excess Tax Benefit Percent
EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent
pure
CY2023 us-gaap Effective Income Tax Rate Reconciliation Other Reconciling Items Percent
EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent
pure
CY2023 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
CY2023 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
pure
CY2022 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
CY2022 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
pure
CY2021 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
CY2021 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
pure
CY2020Q4 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
usd
CY2023Q4 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
usd
CY2022Q4 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
usd
CY2020Q4 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
usd
CY2023 dei Document Type
DocumentType
10-K
CY2023 dei Document Annual Report
DocumentAnnualReport
true
CY2023 dei Document Period End Date
DocumentPeriodEndDate
2023-12-31
CY2023 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2023 dei Document Transition Report
DocumentTransitionReport
false
CY2023 dei Entity File Number
EntityFileNumber
001-40766
CY2023 dei Entity Registrant Name
EntityRegistrantName
Lightwave Logic, Inc.
CY2023 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
NV
CY2023 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
82-0497368
CY2023 dei Entity Address Address Line1
EntityAddressAddressLine1
369 Inverness Parkway
CY2023 dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 350
CY2023 dei Entity Address City Or Town
EntityAddressCityOrTown
Englewood
CY2023 dei Entity Address State Or Province
EntityAddressStateOrProvince
CO
CY2023 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
80112
CY2023 dei City Area Code
CityAreaCode
720
CY2023 dei Local Phone Number
LocalPhoneNumber
340-4949
CY2023 dei Security12b Title
Security12bTitle
Common Stock, $0.001 par value per share
CY2023 dei Trading Symbol
TradingSymbol
LWLG
CY2023 dei Security Exchange Name
SecurityExchangeName
NASDAQ
CY2023 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2023 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2023 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2023 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2023 dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
CY2023 dei Entity Small Business
EntitySmallBusiness
false
CY2023 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2023 dei Icfr Auditor Attestation Flag
IcfrAuditorAttestationFlag
true
CY2023 dei Document Fin Stmt Error Correction Flag
DocumentFinStmtErrorCorrectionFlag
false
CY2023 dei Entity Shell Company
EntityShellCompany
false
CY2023Q2 dei Entity Public Float
EntityPublicFloat
805311165 usd
CY2024Q1 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
119184778 shares
CY2023 dei Auditor Firm
AuditorFirmId
536
CY2023 dei Auditor Name
AuditorName
Morison Cogen LLP
CY2023 dei Auditor Location
AuditorLocation
Blue Bell, Pennsylvania
CY2023Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
31432087 usd
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
24102151 usd
CY2023Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
30376 usd
CY2023Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
1237621 usd
CY2022Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
611345 usd
CY2022Q4 us-gaap Accounts And Notes Receivable Net
AccountsAndNotesReceivableNet
642120 usd
CY2023Q4 us-gaap Assets Current
AssetsCurrent
32700084 usd
CY2022Q4 us-gaap Assets Current
AssetsCurrent
25355616 usd
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
4990790 usd
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
2519267 usd
CY2023Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
1254501 usd
CY2022Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
1030335 usd
CY2023Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
2838210 usd
CY2022Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
358254 usd
CY2023Q4 us-gaap Other Assets
OtherAssets
4092711 usd
CY2022Q4 us-gaap Other Assets
OtherAssets
1388589 usd
CY2023Q4 us-gaap Assets
Assets
41783585 usd
CY2022Q4 us-gaap Assets
Assets
29263472 usd
CY2023Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
1447596 usd
CY2022Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
791671 usd
CY2023Q4 us-gaap Accrued Bonuses Current
AccruedBonusesCurrent
599430 usd
CY2022Q4 us-gaap Accrued Bonuses Current
AccruedBonusesCurrent
380280 usd
CY2023Q4 lwlg Accounts Payable Related Party Current
AccountsPayableRelatedPartyCurrent
313483 usd
CY2022Q4 lwlg Accounts Payable Related Party Current
AccountsPayableRelatedPartyCurrent
100169 usd
CY2023Q4 us-gaap Deferred Revenue
DeferredRevenue
39875 usd
CY2023Q4 lwlg Deferred Lease Liability Current
DeferredLeaseLiabilityCurrent
38297 usd
CY2022Q4 lwlg Deferred Lease Liability Current
DeferredLeaseLiabilityCurrent
41778 usd
CY2023Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
144120 usd
CY2022Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
190125 usd
CY2023Q4 us-gaap Liabilities Current
LiabilitiesCurrent
2582801 usd
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
1504023 usd
CY2022Q4 lwlg Deferred Lease Liability Non Current
DeferredLeaseLiabilityNonCurrent
38297 usd
CY2023Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
2766970 usd
CY2022Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
168129 usd
CY2023Q4 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
2766970 usd
CY2022Q4 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
206426 usd
CY2023Q4 us-gaap Liabilities
Liabilities
5349771 usd
CY2022Q4 us-gaap Liabilities
Liabilities
1710449 usd
CY2023Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2022Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2023Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000 shares
CY2022Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000 shares
CY2023Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2023Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2022Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2022Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
250000000 shares
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
250000000 shares
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
118137309 shares
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
118137309 shares
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
112882793 shares
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
112882793 shares
CY2023Q4 us-gaap Common Stock Value
CommonStockValue
118137 usd
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
112883 usd
CY2023Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
164619363 usd
CY2022Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
134406825 usd
CY2023Q4 us-gaap Deferred Compensation Equity
DeferredCompensationEquity
432293 usd
CY2022Q4 us-gaap Deferred Compensation Equity
DeferredCompensationEquity
133324 usd
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-127871393 usd
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-106833361 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
36433814 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
27553023 usd
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
41783585 usd
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
29263472 usd
CY2023 us-gaap Revenues
Revenues
40502 usd
CY2023 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
2513 usd
CY2023 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
15903689 usd
CY2022 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
12805374 usd
CY2021 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
12476040 usd
CY2023 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
5359565 usd
CY2022 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
4334290 usd
CY2021 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
4520403 usd
CY2023 us-gaap Costs And Expenses
CostsAndExpenses
21265767 usd
CY2022 us-gaap Costs And Expenses
CostsAndExpenses
17139664 usd
CY2021 us-gaap Costs And Expenses
CostsAndExpenses
16996443 usd
CY2023 us-gaap Operating Income Loss
OperatingIncomeLoss
-21225265 usd
CY2022 us-gaap Operating Income Loss
OperatingIncomeLoss
-17139664 usd
CY2021 us-gaap Operating Income Loss
OperatingIncomeLoss
-16996443 usd
CY2021 lwlg Paycheck Protection Program Loan Forgiveness
PaycheckProtectionProgramLoanForgiveness
410700 usd
CY2023 us-gaap Investment Income Interest
InvestmentIncomeInterest
657546 usd
CY2022 us-gaap Investment Income Interest
InvestmentIncomeInterest
91659 usd
CY2021 us-gaap Investment Income Interest
InvestmentIncomeInterest
13826 usd
CY2023 us-gaap Interest Expense
InterestExpense
673578 usd
CY2022 us-gaap Interest Expense
InterestExpense
209709 usd
CY2021 us-gaap Interest Expense
InterestExpense
2059464 usd
CY2023 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
215509 usd
CY2023 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-12244 usd
CY2022 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
27234 usd
CY2023 us-gaap Net Income Loss
NetIncomeLoss
-21038032 usd
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-17230480 usd
CY2021 us-gaap Net Income Loss
NetIncomeLoss
-18631381 usd
CY2023 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.18
CY2022 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.15
CY2021 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.18
CY2023 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.18
CY2022 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.15
CY2021 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.18
CY2023 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
115467300 shares
CY2022 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
111814926 shares
CY2021 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
105223959 shares
CY2023 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
115467300 shares
CY2022 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
111814926 shares
CY2021 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
105223959 shares
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
27553023 usd
CY2023 lwlg Common Stock Issued To Institutional Investor
CommonStockIssuedToInstitutionalInvestor
19993359 usd
CY2023 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
673578 usd
CY2023 lwlg Common Stock Sales At Market By Investment Banking Company
CommonStockSalesAtMarketByInvestmentBankingCompany
1515878 usd
CY2023 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
777674 usd
CY2023 lwlg Stock Issued During Period Value Warrants Exercised
StockIssuedDuringPeriodValueWarrantsExercised
236250 usd
CY2023 us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
6459387 usd
CY2023 us-gaap Deferred Compensation Arrangement With Individual Allocated Share Based Compensation Expense
DeferredCompensationArrangementWithIndividualAllocatedShareBasedCompensationExpense
262697 usd
CY2023 us-gaap Profit Loss
ProfitLoss
-21038032 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
36433814 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
25204272 usd
CY2022 lwlg Common Stock Issued To Institutional Investor
CommonStockIssuedToInstitutionalInvestor
12775268 usd
CY2022 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
209709 usd
CY2022 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
257895 usd
CY2022 lwlg Stock Issued During Period Shares Stock Option Exercised Cashless
StockIssuedDuringPeriodSharesStockOptionExercisedCashless
4375 shares
CY2022 lwlg Cashless Exercise Of Options
CashlessExerciseOfOptions
35018 usd
CY2022 lwlg Stock Issued During Period Value Warrants Exercised
StockIssuedDuringPeriodValueWarrantsExercised
396000 usd
CY2022 us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
5813628 usd
CY2022 us-gaap Deferred Compensation Arrangement With Individual Allocated Share Based Compensation Expense
DeferredCompensationArrangementWithIndividualAllocatedShareBasedCompensationExpense
91713 usd
CY2022 us-gaap Profit Loss
ProfitLoss
-17230480 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
27553023 usd
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
5775446 usd
CY2021 lwlg Common Stock Issued To Institutional Investor
CommonStockIssuedToInstitutionalInvestor
30350674 usd
CY2021 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
2059464 usd
CY2021 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
1950875 usd
CY2021 lwlg Stock Issued During Period Shares Stock Option Exercised Cashless
StockIssuedDuringPeriodSharesStockOptionExercisedCashless
445252 shares
CY2021 lwlg Cashless Exercise Of Options
CashlessExerciseOfOptions
2236858 usd
CY2021 lwlg Stock Issued During Period Value Warrants Exercised
StockIssuedDuringPeriodValueWarrantsExercised
428350 usd
CY2021 us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
1022985 usd
CY2021 us-gaap Adjustments To Additional Paid In Capital Warrant Issued
AdjustmentsToAdditionalPaidInCapitalWarrantIssued
11001 usd
CY2021 us-gaap Profit Loss
ProfitLoss
-18631381 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
25204272 usd
CY2023 us-gaap Net Income Loss
NetIncomeLoss
-21038032 usd
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-17230480 usd
CY2021 us-gaap Net Income Loss
NetIncomeLoss
-18631381 usd
CY2021 us-gaap Adjustment Of Warrants Granted For Services
AdjustmentOfWarrantsGrantedForServices
11001 usd
CY2023 us-gaap Stock Option Plan Expense
StockOptionPlanExpense
6459387 usd
CY2022 us-gaap Stock Option Plan Expense
StockOptionPlanExpense
5813628 usd
CY2021 us-gaap Stock Option Plan Expense
StockOptionPlanExpense
1022985 usd
CY2023 lwlg Amortization Of Deferred Compensation
AmortizationOfDeferredCompensation
262697 usd
CY2022 lwlg Amortization Of Deferred Compensation
AmortizationOfDeferredCompensation
91713 usd
CY2022 lwlg Cashless Option Exercise
CashlessOptionExercise
53219 usd
CY2021 lwlg Cashless Option Exercise
CashlessOptionExercise
3407444 usd
CY2023 us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
673578 usd
CY2022 us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
209709 usd
CY2021 us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
2059464 usd
CY2023 us-gaap Depreciation And Amortization
DepreciationAndAmortization
1119141 usd
CY2022 us-gaap Depreciation And Amortization
DepreciationAndAmortization
1045208 usd
CY2021 us-gaap Depreciation And Amortization
DepreciationAndAmortization
878520 usd
CY2023 us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
184835 usd
CY2022 us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
178192 usd
CY2021 us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
167007 usd
CY2023 lwlg Gain On Disposal Of Property And Equipment
GainOnDisposalOfPropertyAndEquipment
215509 usd
CY2021 lwlg Paycheck Protection Program Loan Forgiveness
PaycheckProtectionProgramLoanForgiveness
410700 usd
CY2023 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
30376 usd
CY2023 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
587540 usd
CY2022 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
379037 usd
CY2021 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-334877 usd
CY2023 lwlg Increase Decrease In Account Payable
IncreaseDecreaseInAccountPayable
655925 usd
CY2022 lwlg Increase Decrease In Account Payable
IncreaseDecreaseInAccountPayable
575937 usd
CY2021 lwlg Increase Decrease In Account Payable
IncreaseDecreaseInAccountPayable
46487 usd
CY2023 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
219150 usd
CY2022 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-737800 usd
CY2021 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
1036684 usd
CY2023 us-gaap Increase Decrease In Accounts Payable Related Parties
IncreaseDecreaseInAccountsPayableRelatedParties
213314 usd
CY2022 us-gaap Increase Decrease In Accounts Payable Related Parties
IncreaseDecreaseInAccountsPayableRelatedParties
67980 usd
CY2021 us-gaap Increase Decrease In Accounts Payable Related Parties
IncreaseDecreaseInAccountsPayableRelatedParties
-17608 usd
CY2023 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
39875 usd
CY2023 lwlg Increase Decrease In Deferred Lease Liability
IncreaseDecreaseInDeferredLeaseLiability
-41778 usd
CY2022 lwlg Increase Decrease In Deferred Lease Liability
IncreaseDecreaseInDeferredLeaseLiability
-41778 usd
CY2021 lwlg Increase Decrease In Deferred Lease Liability
IncreaseDecreaseInDeferredLeaseLiability
-41778 usd
CY2023 us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-150691 usd
CY2022 us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-178192 usd
CY2021 us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-167007 usd
CY2023 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-12236024 usd
CY2022 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-10531701 usd
CY2021 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-10304005 usd
CY2023 us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
307687 usd
CY2022 us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
260415 usd
CY2021 us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
18649 usd
CY2023 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
3292224 usd
CY2022 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
1307187 usd
CY2021 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
1097530 usd
CY2023 lwlg Repayment Issuance Of Loan
RepaymentIssuanceOfLoan
642120 usd
CY2022 lwlg Repayment Issuance Of Loan
RepaymentIssuanceOfLoan
-642120 usd
CY2023 us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
590 usd
CY2023 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-2957201 usd
CY2022 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-2209722 usd
CY2021 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-1116179 usd
CY2023 lwlg Proceeds From Exercise Of Options And Warrants
ProceedsFromExerciseOfOptionsAndWarrants
1013924 usd
CY2022 lwlg Proceeds From Exercise Of Options And Warrants
ProceedsFromExerciseOfOptionsAndWarrants
653895 usd
CY2021 lwlg Proceeds From Exercise Of Options And Warrants
ProceedsFromExerciseOfOptionsAndWarrants
2379225 usd
CY2022 lwlg Cashless Option Exercise Tax Payments
CashlessOptionExerciseTaxPayments
18201 usd
CY2021 lwlg Cashless Option Exercise Tax Payments
CashlessOptionExerciseTaxPayments
1170586 usd
CY2023 lwlg Common Stock Issued To Institutional Investor Value
CommonStockIssuedToInstitutionalInvestorValue
19993359 usd
CY2022 lwlg Common Stock Issued To Institutional Investor Value
CommonStockIssuedToInstitutionalInvestorValue
12775268 usd
CY2021 lwlg Common Stock Issued To Institutional Investor Value
CommonStockIssuedToInstitutionalInvestorValue
30350674 usd
CY2023 lwlg At Market Sale By Investment Banking Company
AtMarketSaleByInvestmentBankingCompany
1515878 usd
CY2021 lwlg Repayment Of Equipment Purchased
RepaymentOfEquipmentPurchased
13107 usd
CY2023 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
22523161 usd
CY2022 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
13410962 usd
CY2021 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
31546206 usd
CY2023 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
7329936 usd
CY2022 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
669539 usd
CY2021 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
20126022 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
24102151 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
23432612 usd
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
3306590 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
31432087 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
24102151 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
23432612 usd
CY2023 lwlg Operating Leases Liability
OperatingLeasesLiability
2703527 usd
CY2023 us-gaap Use Of Estimates
UseOfEstimates
<p id="xdx_84A_eus-gaap--UseOfEstimates_zWZcRsaOO8Wg" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="text-decoration: none"><b><span id="xdx_864_zEDPDU1Hyusl">Estimates</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-align: justify">The preparation of financial statements in conformity with accounting principles generally accepted in the United States requires management to make estimates and assumptions that affect the amounts reported in the financial statements and accompanying disclosures. Although these estimates are based on management’s best knowledge of current events and actions the Company may undertake in the future, actual results could differ from the estimates.</p>
CY2023 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p id="xdx_84B_eus-gaap--ConcentrationRiskCreditRisk_zv0h9tlvphfi" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="text-decoration: none"><b><span id="xdx_864_zcD0N2Rpw9Xj">Concentration of Credit Risk</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Certain financial instruments potentially subject the Company to concentrations of credit risk. These financial instruments consist primarily of cash. At December 31, 2023, the Company did have deposits with a financial institution that exceed the Federal Depository Insurance coverage.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p>
CY2023Q4 us-gaap Property Plant And Equipment Useful Life
PropertyPlantAndEquipmentUsefulLife
P5Y
CY2023Q4 us-gaap Finite Lived Intangible Asset Useful Life
FiniteLivedIntangibleAssetUsefulLife
P20Y
CY2023 lwlg Revenue Recognition And Deferred Revenue
RevenueRecognitionAndDeferredRevenue
<p id="xdx_846_ecustom--RevenueRecognitionAndDeferredRevenue_zDTCNMd5Qt15" style="font: 10pt Times New Roman, Times, Serif; margin: 0"><b><span id="xdx_86F_zETYeKom3x3">Revenue Recognition and Deferred Revenue</span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The rights and benefits to the Company’s patented electro-optic polymer materials are conveyed to the customer through technology license and material supply agreements where the Company provides the licensee a supply of its proprietary polymers for use in the licensee’s manufacturing of photonic devices (the “Licensed Product”) as well as non-exclusive, royalty-bearing license to intellectual property rights in the Company’s patented polymer technology. The Company receives license and royalty payments under such commercial agreements, some of which are nonrefundable upfront payments for license fees. These advances are initially recorded as deferred revenue on the Company’s balance sheets. The Company believes that the licenses provided and materials transferred under such agreements are not distinct from each other for financial reporting purposes and as such, they are accounted for as a single performance obligation. Advance payments for license fees and minimum annual royalties are recognized on a pro-rata basis over the related contract term. Royalties from licensee’s sale of the Licensed Product that exceed the minimum annual royalty are recognized when cumulative royalties exceed the minimum royalty. Milestone license fees are recognized when the licensee reaches the milestone of selling a contractually specified number of units of the Licensed Product.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Revenue associated with the sale of the Company’s patented electro-optic polymer materials for incorporation into the customers’ commercial photonic devices or for their device development and evaluation activities will be recognized at the time title passes, which is typically at the time of shipment or at the time of delivery, depending upon the contractual agreement between the parties.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><b> </b></p>
CY2023 us-gaap Prior Period Reclassification Adjustment Description
PriorPeriodReclassificationAdjustmentDescription
<p id="xdx_847_eus-gaap--PriorPeriodReclassificationAdjustmentDescription_zDXcZnRTgdZ9" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><span id="xdx_865_zXNpSe65kXw5">Reclassifications</span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b> </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span>Certain reclassifications have been made to the 2022 financial statement in order to conform to the 2023 financial statement presentation.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p>
CY2023 lwlg Expected Expenditures Per Month
ExpectedExpendituresPerMonth
1830000 usd
CY2023 us-gaap Royalty Income Nonoperating
RoyaltyIncomeNonoperating
50000 usd
CY2023Q4 us-gaap Deferred Revenue
DeferredRevenue
39875 usd
CY2023Q4 us-gaap Accounts Receivable Net
AccountsReceivableNet
30376 usd
CY2023Q4 us-gaap Deferred Revenue
DeferredRevenue
39875 usd
CY2022 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
0 usd
CY2023Q4 lwlg Prepaid Materials Fabrication
PrepaidMaterialsFabrication
475936 usd
CY2023Q4 lwlg Prepaid License
PrepaidLicense
241936 usd
CY2022Q4 lwlg Prepaid License
PrepaidLicense
94195 usd
CY2023Q4 us-gaap Prepaid Insurance
PrepaidInsurance
237791 usd
CY2022Q4 us-gaap Prepaid Insurance
PrepaidInsurance
218767 usd
CY2023Q4 lwlg Prototype Devices
PrototypeDevices
161267 usd
CY2022Q4 lwlg Prototype Devices
PrototypeDevices
40473 usd
CY2023Q4 us-gaap Other Prepaid Expense Current
OtherPrepaidExpenseCurrent
53373 usd
CY2022Q4 us-gaap Other Prepaid Expense Current
OtherPrepaidExpenseCurrent
45675 usd
CY2023Q4 us-gaap Prepaid Rent
PrepaidRent
36525 usd
CY2022Q4 us-gaap Prepaid Rent
PrepaidRent
36525 usd
CY2023Q4 us-gaap Deposits Assets Current
DepositsAssetsCurrent
20000 usd
CY2022Q4 us-gaap Deposits Assets Current
DepositsAssetsCurrent
59850 usd
CY2023Q4 lwlg Investor Relations
InvestorRelations
6313 usd
CY2022Q4 lwlg Investor Relations
InvestorRelations
18250 usd
CY2023Q4 lwlg Leases Incentive Receivable
LeasesIncentiveReceivable
4480 usd
CY2022Q4 lwlg Legal
Legal
83941 usd
CY2022Q4 us-gaap Other Receivables Net Current
OtherReceivablesNetCurrent
13669 usd
CY2023Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
1237621 usd
CY2022Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
611345 usd
CY2023Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
9665350 usd
CY2022Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
6572152 usd
CY2023Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
4674560 usd
CY2022Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
4052885 usd
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
4990790 usd
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
2519267 usd
CY2023 us-gaap Depreciation
Depreciation
1035620 usd
CY2022 us-gaap Depreciation
Depreciation
966995 usd
CY2021 us-gaap Depreciation
Depreciation
792004 usd
CY2023 us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
590 usd
CY2023 lwlg Trade In Credit
TradeInCredit
216090 usd
CY2023 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
215509 usd
CY2022 lwlg Leasehold Improvements
LeaseholdImprovements
70963 usd
CY2021 lwlg Retire Property And Equipment
RetirePropertyAndEquipment
0 usd
CY2023Q4 us-gaap Finite Lived Patents Gross
FiniteLivedPatentsGross
1913751 usd
CY2022Q4 us-gaap Finite Lived Patents Gross
FiniteLivedPatentsGross
1606064 usd
CY2023Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
659250 usd
CY2022Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
575729 usd
CY2023Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
1254501 usd
CY2022Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
1030335 usd
CY2023 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
83521 usd
CY2022 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
78213 usd
CY2021 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
86516 usd
CY2023 us-gaap Impairment Of Intangible Assets Finitelived
ImpairmentOfIntangibleAssetsFinitelived
0 usd
CY2022 us-gaap Impairment Of Intangible Assets Finitelived
ImpairmentOfIntangibleAssetsFinitelived
0 usd
CY2021 us-gaap Impairment Of Intangible Assets Finitelived
ImpairmentOfIntangibleAssetsFinitelived
0 usd
CY2017Q4 us-gaap Lessee Operating Lease Term Of Contract
LesseeOperatingLeaseTermOfContract
P61M
CY2017Q4 lwlg Lease Beginning Date1
LeaseBeginningDate1
2017-11-01
CY2017Q4 us-gaap Lease Expiration Date1
LeaseExpirationDate1
2022-11-30
CY2017Q4 us-gaap Lessee Operating Lease Renewal Term
LesseeOperatingLeaseRenewalTerm
P24M
CY2017Q4 us-gaap Operating Leases Future Minimum Payments Due Current
OperatingLeasesFutureMinimumPaymentsDueCurrent
168824 usd
CY2017Q4 lwlg Percentage Of Rent Increase Annual Base Rent
PercentageOfRentIncreaseAnnualBaseRent
0.03 pure
CY2017Q4 lwlg Prepaid Rents
PrepaidRents
347045 usd
CY2017Q4 lwlg Prepaid Estimated Tenants Proportionate Share Of Operating Lease Expenses
PrepaidEstimatedTenantsProportionateShareOfOperatingLeaseExpenses
186293 usd
CY2017Q4 us-gaap Security Deposit
SecurityDeposit
36525 usd
CY2017Q4 us-gaap Operating Leases Rent Expense Sublease Rentals1
OperatingLeasesRentExpenseSubleaseRentals1
260000 usd
CY2019Q4 lwlg Percentage Of Estimated Incremental Borrowing Rate
PercentageOfEstimatedIncrementalBorrowingRate
0.065 pure
CY2019Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
885094 usd
CY2022Q4 us-gaap Lessee Operating Lease Term Of Contract
LesseeOperatingLeaseTermOfContract
P128M
CY2022Q4 us-gaap Lease Expiration Date1
LeaseExpirationDate1
2023-06-01
CY2022Q4 lwlg Base Rent
BaseRent
30517 usd
CY2022Q4 us-gaap Operating Leases Future Minimum Payments Due Current
OperatingLeasesFutureMinimumPaymentsDueCurrent
377288 usd
CY2022Q4 lwlg Percentage Of Rent Increase Annual Base Rent
PercentageOfRentIncreaseAnnualBaseRent
0.03 pure
CY2022Q4 lwlg Lease Allowance
LeaseAllowance
43216 usd
CY2023Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
2945322 usd
CY2023Q4 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
376364 usd
CY2023Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
387666 usd
CY2023Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
399199 usd
CY2023Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
411174 usd
CY2023Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Five
LesseeOperatingLeaseLiabilityPaymentsDueYearFive
423612 usd
CY2023Q4 lwlg Lessee Operating Lease Liability Payments Due After Year Four
LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour
2357570 usd
CY2023Q4 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
4355585 usd
CY2023Q4 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
1444495 usd
CY2023Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
2911090 usd
CY2023 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-6526000 usd
CY2022 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-5071000 usd
CY2021 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-3692000 usd
CY2023 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
6526000 usd
CY2022 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
5071000 usd
CY2021 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
3692000 usd
CY2023 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
-4418000 usd
CY2023 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21 pure
CY2022 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
-3618000 usd
CY2022 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21 pure
CY2021 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
-3913000 usd
CY2021 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21 pure
CY2023 us-gaap Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
-957000 usd
CY2023 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0.05 pure
CY2022 us-gaap Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
-784000 usd
CY2022 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0.04 pure
CY2021 us-gaap Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
-838000 usd
CY2021 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0.04 pure
CY2023 us-gaap Income Tax Reconciliation Deductions
IncomeTaxReconciliationDeductions
44000 usd
CY2022 us-gaap Income Tax Reconciliation Deductions
IncomeTaxReconciliationDeductions
35000 usd
CY2021 us-gaap Income Tax Reconciliation Deductions
IncomeTaxReconciliationDeductions
38000 usd
CY2021 us-gaap Income Tax Reconciliation Tax Exempt Income
IncomeTaxReconciliationTaxExemptIncome
-111000 usd
CY2021 us-gaap Effective Income Tax Rate Reconciliation Tax Exempt Income
EffectiveIncomeTaxRateReconciliationTaxExemptIncome
0.01 pure
CY2023 us-gaap Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost
IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost
1653000 usd
CY2023 us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense Share Based Compensation Cost
EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost
0.08 pure
CY2022 us-gaap Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost
IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost
1430000 usd
CY2022 us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense Share Based Compensation Cost
EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost
0.08 pure
CY2021 us-gaap Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost
IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost
899000 usd
CY2021 us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense Share Based Compensation Cost
EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost
0.05 pure
CY2023 us-gaap Effective Income Tax Rate Reconciliation Share Based Compensation Excess Tax Benefit Amount
EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount
-2850000 usd
CY2023 us-gaap Effective Income Tax Rate Reconciliation Share Based Compensation Excess Tax Benefit Percent
EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent
0.13 pure
CY2022 us-gaap Effective Income Tax Rate Reconciliation Share Based Compensation Excess Tax Benefit Amount
EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount
-2981000 usd
CY2022 us-gaap Effective Income Tax Rate Reconciliation Share Based Compensation Excess Tax Benefit Percent
EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent
0.17 pure
CY2023 us-gaap Income Tax Reconciliation Other Reconciling Items
IncomeTaxReconciliationOtherReconcilingItems
2000 usd
CY2022 us-gaap Income Tax Reconciliation Other Reconciling Items
IncomeTaxReconciliationOtherReconcilingItems
847000 usd
CY2022 us-gaap Effective Income Tax Rate Reconciliation Other Reconciling Items Percent
EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent
0.05 pure
CY2021 us-gaap Income Tax Reconciliation Other Reconciling Items
IncomeTaxReconciliationOtherReconcilingItems
233000 usd
CY2021 us-gaap Effective Income Tax Rate Reconciliation Other Reconciling Items Percent
EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent
0.01 pure
CY2023 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
6526000 usd
CY2023 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
0.31 pure
CY2022 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
5071000 usd
CY2022 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
0.29 pure
CY2021 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
3692000 usd
CY2021 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
0.20 pure
CY2023Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
29018000 usd
CY2022Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
23930000 usd
CY2020Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
19966000 usd
CY2023Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
3889000 usd
CY2022Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
2451000 usd
CY2020Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
1242000 usd
CY2023Q4 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
-102000 usd
CY2022Q4 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
-102000 usd
CY2023Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
32805000 usd
CY2022Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
26279000 usd
CY2020Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
21208000 usd
CY2023Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
32805000 usd
CY2022Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
26279000 usd
CY2021Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
21208000 usd
CY2023 us-gaap Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
6526000 usd
CY2022 us-gaap Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
5071000 usd
CY2021 us-gaap Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
3692000 usd
CY2023Q4 us-gaap Operating Loss Carryforwards
OperatingLossCarryforwards
117985000 usd
CY2018Q1 us-gaap Operating Loss Carryforwards
OperatingLossCarryforwards
38275000 usd
CY2023 us-gaap Operating Loss Carryforwards Expiration Date
OperatingLossCarryforwardsExpirationDate
2038-12-31
CY2018Q1 us-gaap Operating Loss Carryforwards
OperatingLossCarryforwards
79710000 usd
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
5291784 shares
CY2023 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Method Used
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsMethodUsed
Black-Scholes
CY2023 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0 pure
CY2023 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P10Y
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0 pure
CY2022 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P10Y
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0 pure
CY2021 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P10Y
CY2023Q4 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
3295335 usd
CY2023 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
6722084 usd
CY2022 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
5905341 usd
CY2021 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1033986 usd
CY2023Q4 lwlg Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value Options
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValueOptions
24308723 usd
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue
24214724 usd
CY2023Q4 us-gaap Share Price
SharePrice
4.98
CY2023 lwlg Stocks Issued During Period Shares Stock Options Exercised
StocksIssuedDuringPeriodSharesStockOptionsExercised
914408 shares
CY2023Q4 lwlg Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Aggregate Intrinsic Values
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValues
4698996 usd
CY2023 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
777674 usd
CY2023 lwlg Stock Issued During Period Shares Stock Warrants Exercised
StockIssuedDuringPeriodSharesStockWarrantsExercised
269000 shares
CY2023 lwlg Stock Issued During Period Shares Stock Warrants Exercised Value
StockIssuedDuringPeriodSharesStockWarrantsExercisedValue
1162230 usd
CY2023 us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
236250 usd
CY2022 lwlg Stocks Issued During Period Shares Stock Options Exercised
StocksIssuedDuringPeriodSharesStockOptionsExercised
302950 shares
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue
2920861 usd
CY2022 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
257895 usd
CY2022 lwlg Stock Issued During Period Shares Stock Options Exercised Cashless
StockIssuedDuringPeriodSharesStockOptionsExercisedCashless
4375 shares
CY2022 lwlg Stock Issued During Period Shares Stock Options Exercised Cashless Aggregate Intrinsic Value
StockIssuedDuringPeriodSharesStockOptionsExercisedCashlessAggregateIntrinsicValue
53219 usd
CY2022 lwlg Stock Issued During Period Shares Stock Warrants Exercised
StockIssuedDuringPeriodSharesStockWarrantsExercised
350000 shares
CY2022 lwlg Stock Issued During Period Shares Stock Warrants Exercised Aggregate Intrinsic Value
StockIssuedDuringPeriodSharesStockWarrantsExercisedAggregateIntrinsicValue
2555750 usd
CY2022 us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
396000 usd
CY2021 lwlg Stocks Issued During Period Shares Stock Options Exercised
StocksIssuedDuringPeriodSharesStockOptionsExercised
2046250 shares
CY2021 lwlg Stocks Issued During Period Shares Stock Options Exercised Aggregate Intrinsic Value
StocksIssuedDuringPeriodSharesStockOptionsExercisedAggregateIntrinsicValue
22351788 usd
CY2021 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
1950875 usd
CY2021 lwlg Stock Issued During Period Shares Stock Warrants Exercised
StockIssuedDuringPeriodSharesStockWarrantsExercised
677000 shares
CY2021 lwlg Stock Issued During Period Shares Stock Warrants Exercised Aggregate Intrinsic Value
StockIssuedDuringPeriodSharesStockWarrantsExercisedAggregateIntrinsicValue
6796400 usd
CY2021 us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
428350 usd
CY2021 lwlg Stock Issued During Period Shares Stock Options Exercised Cashless
StockIssuedDuringPeriodSharesStockOptionsExercisedCashless
445252 shares
CY2021 lwlg Stock Issued During Period Shares Stock Options Exercised Cashless Aggregate Intrinsic Value
StockIssuedDuringPeriodSharesStockOptionsExercisedCashlessAggregateIntrinsicValue
3406530 usd
CY2023Q4 us-gaap Unamortized Debt Issuance Expense
UnamortizedDebtIssuanceExpense
432292 usd
CY2022Q4 us-gaap Unamortized Debt Issuance Expense
UnamortizedDebtIssuanceExpense
133324 usd
CY2023 us-gaap Defined Contribution Plan Cost Recognized
DefinedContributionPlanCostRecognized
72570 usd
CY2022 us-gaap Defined Contribution Plan Cost Recognized
DefinedContributionPlanCostRecognized
57126 usd
CY2021 us-gaap Defined Contribution Plan Cost Recognized
DefinedContributionPlanCostRecognized
53035 usd

Files In Submission

Name View Source Status
lwlg-20231231_cal.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
0001079973-24-000315-index-headers.html Edgar Link pending
0001079973-24-000315-index.html Edgar Link pending
0001079973-24-000315.txt Edgar Link pending
0001079973-24-000315-xbrl.zip Edgar Link pending
ex19x1.htm Edgar Link pending
ex21x1.htm Edgar Link pending
ex23x1.htm Edgar Link pending
ex31x1.htm Edgar Link pending
ex31x2.htm Edgar Link pending
ex32x1.htm Edgar Link pending
ex32x2.htm Edgar Link pending
ex4x1.htm Edgar Link pending
ex97x1.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
image_001.gif Edgar Link pending
image_001.jpg Edgar Link pending
image_003.jpg Edgar Link pending
image_004.jpg Edgar Link pending
image_005.jpg Edgar Link pending
image_006.jpg Edgar Link pending
image_007.jpg Edgar Link pending
image_013.jpg Edgar Link pending
image_015.jpg Edgar Link pending
image_019.jpg Edgar Link pending
image_020.jpg Edgar Link pending
image_023.jpg Edgar Link pending
image_024.jpg Edgar Link pending
image_025.jpg Edgar Link pending
image_026.jpg Edgar Link pending
image_027.jpg Edgar Link pending
image_029.jpg Edgar Link pending
lwlg-20231231.xsd Edgar Link pending
lwlg_10k-123123.htm Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
lwlg-20231231_def.xml Edgar Link unprocessable
lwlg-20231231_lab.xml Edgar Link unprocessable
lwlg-20231231_pre.xml Edgar Link unprocessable
lwlg_10k-123123_htm.xml Edgar Link completed
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending